2020 American Transplant Congress
Comparison of Basiliximab for Induction Therapy in Kidney Transplant Recipients on Post-Operative Days 0 and 4 versus Post-Operative Days 0 and 3
Pharmacy, CHI St. Luke's Health Baylor St. Luke's Medical Center, Houston, TX
*Purpose: Current dosing recommendations for the administration of basiliximab on post-operative days (POD) 0 and 4 stem from two phase 3 renal transplant studies. Limited…2020 American Transplant Congress
Sirolimus (SRL) versus Everolimus (EVR) versus Mycophenolate (MPA) in Kidney Transplant Recipients Receiving Anti-Thymocyte Globulin Induction (r-ATG), Tacrolimus (TAC), and Prednisone
Nephrology Division, Hospital Do Rim, Sao Paulo, Brazil
*Purpose: The aim of this study is to compare the efficacy and safety of SRL versus EVR versus MPA in kidney transplant recipients*Methods: This is…2020 American Transplant Congress
Adaptive Induction Therapy in Renal Transplant Recipients (RTR) with Donor-Specific Antibody (DSA)
*Purpose: Patients with preformed DSA are at higher risk of developing acute antibody-mediated rejection (ABMR) after kidney transplantation.*Methods: We analyzed consecutive kidney transplant recipients (RTR)…2020 American Transplant Congress
Dose Reduction of Anti-Thymocyte Globulin for Kidney Transplant Induction: Possible Cost Savings?
Rush University Medical Center, Chicago, IL
*Purpose: Based on the United Network of Organ Sharing (UNOS) annual report, there has been an increase in the number of adults ages 65-74 waiting…2020 American Transplant Congress
The Next Era of Living Kidney Donation for Renal Transplantation: Virtual Postoperative Follow-Up
Surgery, Medical University of South Carolina, Charleston, SC
*Purpose: Living kidney donation (LKD) offers the best long-term outcomes for patients undergoing kidney transplantation. However, LKD has been declining in the U.S. in recent…2020 American Transplant Congress
Risk Factors for the Development of Avascular Necrosis: Single Center Experience
*Purpose: Avascular necrosis (AVN) is one of the most common bone complications after kidney transplantation. In recent years, it has become an important morbidity with…2020 American Transplant Congress
Decision-Making, Motivations and the Donation Experience among HLA-Identical Living Kidney Donors at UCLA – A Qualitative Study
*Purpose: Studies on motivations and decision-making processes of living donors have previously identified recipient relationship, fear of loss and altruism as important modifying factors of…2020 American Transplant Congress
Robotic Donor Nephrectomy: A Novel Approach to Improve Living Donor Kidney Transplantation
*Purpose: Robotic assisted live donor nephrectomies (RDN) have continued to gain popularity in recent years. Our purpose was to investigate the difference in outcomes between…2020 American Transplant Congress
Inflammatory Cytokines Have a Different Effect from One HLA-II Subclass to Another on Human Endothelium
Universite Laval, Quebec, QC, Canada
*Purpose: Development of de novo donor-specific antibodies (DSAs) is associated with antibody-mediated rejection and allograft failure. More particularly, HLA-II DSAs, especially those against DQ are…2020 American Transplant Congress
Urine Donor Derived Cell Free DNA Aids in the Diagnosis of BK Polyomavirus Nephropathy in Kidney Transplant Recipients with BK Viruria
*Purpose: BK polyomavirus nephropathy (BKVN) are important cause of dysfunction and failure of renal transplants, which is similar to T cell mediated rejection (TCMR) in…
- « Previous Page
- 1
- …
- 399
- 400
- 401
- 402
- 403
- …
- 1683
- Next Page »